ArticleBMJ open2019

Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol.

Emma Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.